Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.

@article{Kirchhof2012ComprehensiveRR,
  title={Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.},
  author={Paulus Kirchhof and Gregory Y. H. Lip and Isabelle C. van Gelder and Jeroen Bax and Elaine M. Hylek and Stefan Kaab and Ulrich Schotten and Karl Wegscheider and Giuseppe Boriani and Axel Brandes and Michael Ezekowitz and Hans-Christoph Diener and Laurent Haegeli and Hein Heidbuchel and Deirdre Lane and Lu{\'i}s Mont and Stephan Willems and P. Dorian and Maria Aunes-Jansson and Carina Blomstrom-Lundqvist and Maria Borentain and Stefanie Breitenstein and Martina Brueckmann and Nilo B Cater and Andreas Clemens and Dobromir Dobrev and Sergio J. Dubner and Nils G Edvardsson and Leif Friberg and Andreas Goette and Michele Massimo Gulizia and Robert W. Hatala and Jenny Horwood and Lukas Szumowski and Lukas Kappenberger and Josef Kautzner and Angelika Leute and Trudie C A Lobban and Ralf Meyer and Jay Millerhagen and John D Morgan and Felix Muenzel and Michael Nabauer and Christoph Baertels and Michael Oeff and Dieter W Paar and Juergen Polifka and Ursula Ravens and Ludger Rosin and Wim Stegink and Gerhard Steinbeck and Panos Vardas and A. T. Vincent and Maureen V Walter and G{\"u}nter Breithardt and A. John Camm},
  journal={Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology},
  year={2012},
  volume={14 1},
  pages={8-27}
}
While management of atrial fibrillation (AF) patients is improved by guideline-conform application of anticoagulant therapy, rate control, rhythm control, and therapy of accompanying heart disease, the morbidity and mortality associated with AF remain unacceptably high. This paper describes the proceedings of the 3rd Atrial Fibrillation NETwork (AFNET… CONTINUE READING